USPTO serial 88226849
ELFABRIO
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Feb 18, 2020
- Examiner
- JACKSON, SHA-KARA ELOUISE
- Law office
- Historical data usage
What this means
Status 701 means the registration is active and the first Section 8 declaration of continued use was accepted. The next major deadline is the combined Section 8 and Section 9 filing at the 10-year anniversary. Calendar the 10-year Section 8 and 9 combined renewal.
Need help with ELFABRIO?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Maryellen Feehery Hank
Maryellen Feehery Hank Vorys, Sater, Seymour and Pease LLPIPLAW@VORYS -PO BOX 2255Columbus, OH 43216-2255United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations and substances for the treatment of pain, cardiovascular disorders, [ alimentary tract and metabolism problems, respiratory diseases, ] endocrine, [ musculoskeletal, ] cardiopulmonary, [ genitourinary, oncological, ] hepatological, [ ophthalmological, otologicals, ] neurological, [ gastrointestinal, hormonal, ] dermatological and psychiatric related diseases and disorders and for the treatment of damaged skin and tissue; [ anti-inflammatory and anti-rheumatics drugs; pharmaceutical preparations, namely, immunomodulators; pharmaceutical preparations, namely, hematological agents being pharmaceuticals for the treatment of hematological diseases; ] Enzyme replacement therapy preparations; Enzyme replacement therapy products, namely, infusions, liquids [ , tablets and powders ] for human use in the treatment of genetic disorders for medical purposes [ ; Therapeutic cellular and stem cell compositions for medical use ] | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 10, 2026 | NAS8 | NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED | — |
| Jun 10, 2026 | 8.OK | REGISTERED - SEC. 8 (6-YR) ACCEPTED | The USPTO accepted your Section 8 declaration showing the mark is still in use in commerce (or excusable nonuse). This satisfies the six-year maintenance requirement and keeps the registration active until the next renewal deadline. |
| Jun 10, 2026 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Feb 12, 2026 | ES8R | TEAS SECTION 8 RECEIVED | — |
| Feb 18, 2025 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Feb 18, 2020 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jan 14, 2020 | DP1B | 1(B) BASIS DELETED; PROCEED TO REGISTRATION | — |
| Jan 13, 2020 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Dec 9, 2019 | IUCN | NOTICE OF ALLOWANCE CANCELLED | — |
| Dec 9, 2019 | EPPA | TEAS POST PUBLICATION AMENDMENT RECEIVED | — |
| Jul 16, 2019 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| May 21, 2019 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| May 21, 2019 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 1, 2019 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Apr 12, 2019 | ALIE | ASSIGNED TO LIE | — |
| Mar 22, 2019 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 15, 2019 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Mar 15, 2019 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Mar 15, 2019 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Mar 15, 2019 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Mar 11, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 4, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 15, 2018 | NWAP | NEW APPLICATION ENTERED | — |